Anticancer therapies, including chemotherapy, radiation, and targeted therapies, often exacerbate pre-existing cardiovascular and kidney diseases or induce new complications, making the management of CKM essential for optimizing outcomes in cancer patients [109] (Table 5). Here, CKM is linked to cancer.